Participants Named for GRAIL’s Second Multi-Cancer Screening Blood Trial
The University of Illinois Chicago will participate in a study of a test that screens for a shared cancer signal in patient blood samples.
Read MorePosted by Andy Lundin | Oct 18, 2023 | Cancer |
The University of Illinois Chicago will participate in a study of a test that screens for a shared cancer signal in patient blood samples.
Read MorePosted by Andy Lundin | Oct 17, 2023 | Hematology & Serology |
FloBio announced that the U.S. FDA has granted Breakthrough Device Designation for its rapid bleeding risk diagnostic test.
Read MorePosted by Andy Lundin | Oct 16, 2023 | Immunoassay Reagents & test Kits |
Werfen announced 510(k) clearance of Aptiva Connective Tissue Disease (CTD) Essential reagent by the U.S. Food and Drug Administration (FDA).
Read MorePosted by Andy Lundin | Oct 13, 2023 | Hematology & Serology, Tubes |
Taking less blood for lab tests using “small-volume” tubes reduced the need for almost one blood transfusion for every 10 patients.
Read MorePosted by Chris Wolski | Oct 6, 2023 | Analytical Software Systems |
A study showed that remote digital morphology could be used to provide services remotely without disrupting laboratory workflow.
Read More